Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

ASSAY OF CHEMICALS FOR PARKINSON'S TOXICITY IN HUMAN IPSC-DERIVED NEURONS

Export to Word (http://www.niehs.nih.gov//portfolio/index.cfm/portfolio/grantdetail/grant_number/R44ES026268/format/word)
Principal Investigator: Mcdonough, Patrick M
Institute Receiving Award Vala Sciences, Inc.
Location San Diego, CA
Grant Number R44ES026268
Funding Organization National Institute of Environmental Health Sciences
Award Funding Period 01 Sep 2015 to 31 May 2021
DESCRIPTION (provided by applicant): Parkinson’s Disease (PD) afflicts ~1% of humans and prevalence increases with age. Initial symptoms include tremors in extremities, but PD progresses over years, affecting additional limbs, with impairment of mood/behavior/cognition. Familial PD makes up ~10% of cases while certain chemicals/environmental toxicants (e.g., rotenone, paraquat, maneb) increase the risk of PD and much evidence points to genetic x environmental interactions. The overall goal of our project is to develop an assay system, utilizing dopaminergic neurons derived from induced pluripotent stem cells (iPSC-DNs and iPSC-MGs) and automated digital microscopy and associated methods (Kinetic Image Cytometry [KIC] and High Content Analysis [HCA]) to enable screening of environmental toxicants for potential PD toxicity. In phase I we demonstrated that iPSC-DN featuring the A53T-α-Syn mutation (which causes early-onset PD, with high penetrance) have increased spontaneous activity (calcium and voltage transients) and increased sensitivity to PD-linked toxicants vs. neurons with wt-α-Syn, which demonstrates the feasibility of our approach. In Phase II we will collaborate with researchers at The Parkinson’s Institute and Clinical Center, to further develop our assay methods, utilizing iPSC-DNs that feature G2019S-LRRK2, a common, PD-associated mutation, that has very recently been linked to increased susceptibility to environmental toxicants, iPSC lines representing both sexes, and lines derived from subjects with sporadic PD. We will also develop a coculture system with both iPSC-DNs and iPSC-MGs in the culture wells. The resulting assay system will enable the most comprehensive screening of environmental toxicants for potential PD-inducing effects, yet available. Potential customers for the assay include government agencies, such as the US EPA and the National Toxicology Program, and global agencies concerned with the effects of industrial/agricultural chemicals on human health.
Science Code(s)/Area of Science(s) Primary: 17 - Stem Cell Biology and Cellular Differentiation
Publications No publications associated with this grant
Program Officer Daniel Shaughnessy
Back
to Top